Aromatase inhibitors for breast cancer: Advantages over tamoxifen in early-stage disease
Patients survive longer, recurrences occur later, and certain side effects occur less often. Overall, the evidence for late-stage disease is much poorer.
Today's Tech News and Opinion
Leave a Reply